Market Research Report
Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis By Disease (HIV POC, HBV POC, Influenza/Flu POC, TB & drug-resistant TB POC), By End-use, And Segment Forecasts, 2014 - 2025
|Published by||Grand View Research, Inc.||Product code||557223|
|Published||Content info||145 Pages
Delivery time: 2-3 business days
|Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis By Disease (HIV POC, HBV POC, Influenza/Flu POC, TB & drug-resistant TB POC), By End-use, And Segment Forecasts, 2014 - 2025|
|Published: August 17, 2017||Content info: 145 Pages||
The global point-of-care infectious disease diagnostics/testing market is expected to reach USD 1.90 billion by 2025, according to a new report by Grand View Research, Inc. The emerging trend of patient-centric services coupled with escalating incidence rates of complicated infectious disorders is expected to upsurge the demand for portable and accurate detection devices, thus resulting in market growth. The potential in these devices to enable rapid detection of infectious diseases is attributive for the estimated market.
Moreover, revolutionizing patient care brought about by these devices is responsible for the rising demand for decentralized testing settings. Rise in the investments for R&D and development of new products is expected to spur progress in this market through to 2025.
For instance, development of a new 'lab-on-a-disc' technology developed by an EU project research team aids in the diagnosis of different infectious diseases including malaria. It enables faster diagnosis as a consequence of implementation of point-of-care treatment. This allows precise drugs administration thus influencing adoption rate.
The major players in the sector include Siemens Healthineers, Trivitron Healthcare, F. Hoffmann-La Roche Ltd, Alere, Quest Diagnostics, Inc, BD & Company, Chembio Diagnostics Inc,Trinity Biotech, Cardinal Health,Bio-Rad Labs Inc.,bioMerieux SA, Thermo Fisher Scientific Inc, Sight Diagnostics Ltd.,Gene POC, Ortho-Clinical Diagnostics, and OJ-Bio Ltd.